High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins | Zendy

Camilla Smith | Zendy; Bente Halvorsen | Zendy; Kari Otterdal | Zendy; Torgun Wæhre | Zendy; Arne Yndestad | Zendy; Børre Fevang | Zendy; Wiggo J. Sandberg | Zendy; Unni M. Breland | Zendy; S S Frøland | Zendy; Erik Øie | Zendy; Lars Gullestad | Zendy; J Damås | Zendy; P Aukrust | Zendy

Open Access

High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins

Author(s) -

Camilla Smith,

Bente Halvorsen,

Kari Otterdal,

Torgun Wæhre,

Arne Yndestad,

Børre Fevang,

Wiggo J. Sandberg,

Unni M. Breland,

S S Frøland,

Erik Øie,

Lars Gullestad,

J Damås,

P Aukrust

Publication year - 2008

Publication title -

cardiovascular research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.774

H-Index - 219

eISSN - 1755-3245

pISSN - 0008-6363

DOI - 10.1093/cvr/cvn071

Subject(s) - cxcl16 , chemokine , medicine , inflammation , endocrinology , atorvastatin , monocyte , peripheral blood mononuclear cell , immunology , pharmacology , chemistry , cxcl10 , in vitro , biochemistry

CXC ligand 16 (CXCL16) may be involved in inflammation and lipid metabolism, and we hypothesized a role for this chemokine in coronary artery disease (CAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog